Biodesix, Inc. BDSX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $25.56M+42.3% | $28.76M+40.8% | $21.77M+19.9% | $20.02M+11.7% | $17.96M+21.2% | ||
| $3.29M+14.5% | $2.87M+18.9% | $2.99M+17.5% | $3.27M+27.8% | $2.87M+40.7% | ||
| $24.26M+18.6% | $22.97M+13.6% | $21.71M+8.5% | $22.41M+14.0% | $20.45M-0.5% | ||
| $31.76M+17.2% | $30.72M+13.5% | $28.82M+7.8% | $29.74M+13.7% | $27.09M+4.9% | ||
| $31.76M+17.2% | $30.72M+13.5% | $28.82M+7.8% | $29.74M+13.7% | $27.09M+4.9% | ||
| -$6.2M+32.1% | -$1.97M+70.4% | -$7.05M+17.9% | -$9.72M-18.0% | -$9.14M+17.1% | ||
| -24.3%+26.6pp | -6.8%+25.7pp | -32.4%+14.9pp | -48.6%-2.6pp | -50.9%+23.5pp | ||
| $1.98M+17.3% | $2.06M+17.5% | $2.07M+1.6% | $1.9M-2.0% | $1.69M-33.4% | ||
| -$1.59M+19.0% | -$2.01M-25.7% | -$1.67M+0.1% | -$1.75M+32.0% | -$1.97M+24.2% | ||
| -$7.79M+29.8% | -$3.98M+51.8% | -$8.72M+15.0% | -$11.47M-6.1% | -$11.1M+18.5% | ||
| -30.5%+31.3pp | -13.8%+26.5pp | -40%+16.5pp | -57.3%+3.0pp | -61.8%+30.1pp | ||
| -$0.81+46.7% | -$0.43+58.3% | -$1.16+17.1% | -$0.080.0% | -$1.52-986% | ||
| -$0.81+46.7% | -$0.43+58.3% | -$1.16+17.1% | -$0.080.0% | -$1.52-986% | ||
| 9.7M+32.3% | 7.6M+16.7% | 7.5M+2.5% | 146.7M+15.3% | 7.3M-92.5% | ||
| 9.7M+32.3% | 7.6M+16.7% | 7.5M+2.5% | 146.7M+15.3% | 7.3M-92.5% | ||
| $4.21M+13.6% | $4.88M+12.4% | $4.11M-1.7% | $4.03M+4.0% | $3.7M+16.6% | ||
| $5K-93.2% | $1K-99.0% | $7K— | $26K-61.2% | $73K+7.4% | ||
| $385K+293% | —— | $409K+9.4% | $51K+113% | $98K+253% | ||
| -$6.2M+32.1% | -$1.97M+70.4% | -$7.05M+17.9% | -$9.72M-18.0% | -$9.14M+17.1% | ||
| -$4.81M+37.6% | -$580K+88.8% | -$5.65M+20.5% | -$8.28M-21.4% | -$7.7M+19.8% | ||
| -$4.81M+37.6% | -$580K+88.8% | -$5.65M+20.5% | -$8.28M-21.4% | -$7.7M+19.8% | ||
| -18.8%+24.1pp | -2%+23.4pp | -25.9%+13.2pp | -41.4%-3.3pp | -42.9%+21.9pp | ||
| -$6.2M+32.1% | -$1.97M+70.4% | -$7.05M+17.9% | -$9.72M-18.0% | -$9.14M+17.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Biodesix, Inc.'s revenue?
- Biodesix, Inc. (BDSX) generated $96.1M in revenue over the trailing twelve months, up 29.0% year over year.
- Is Biodesix, Inc. profitable?
- Biodesix, Inc. is not currently profitable: it reported a net loss of $32.0M over the trailing twelve months, a -33.3% net margin.
- What is Biodesix, Inc.'s earnings per share?
- Biodesix, Inc.'s diluted EPS over the trailing twelve months is $-2.48.
- Where does Biodesix, Inc.'s income statement data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
